Author

Juan Enrique Dominguez-Munoz

ACCURACY OF INTRACYSTIC CA 72.4 LEVELS FOR THE DIAGNOSIS OF MUCINOUS CYSTIC PANCREATIC LESION
ACCURACY OF INTRACYSTIC CA 72.4 LEVELS FOR THE DIAGNOSIS OF MUCINOUS CYSTIC PANCREATIC LESION

Juan Enrique Dominguez-Munoz  et al.

Which end-points are patient-relevant in clinical trials of chronic pancreatitis?
Which end-points are patient-relevant in clinical trials of chronic pancreatitis?

Juan Enrique Dominguez-Munoz

Mistakes in ... Pancreatic Cyst Neoplasms
Mistakes in ... Pancreatic Cyst Neoplasms

Juan Enrique Dominguez-Munoz  et al.

GI Guidelines Webinar #7 | 13C-breath test: From guidelines to clinical practice
GI Guidelines Webinar #7 | 13C-breath test: From guidelines to clinical practice

Juan Enrique Dominguez-Munoz  et al.

Mistakes in cystic lesions of the pancreas
Mistakes in cystic lesions of the pancreas

Juan Enrique Dominguez-Munoz

European evidencebased guidelines for the diagnosis and therapy of chronic pancreatitis (HaPanEU)
European evidencebased guidelines for the diagnosis and therapy of chronic pancreatitis (HaPanEU)

Juan Enrique Dominguez-Munoz  et al.

ENDOSCOPIC ULTRASOUND GUIDED ELASTOGRAPHY FOR THE DIAGNOSIS OF MALIGNANCY IN RESECTABLE PANCREATIC TUMORS
ENDOSCOPIC ULTRASOUND GUIDED ELASTOGRAPHY FOR THE DIAGNOSIS OF MALIGNANCY IN RESECTABLE PANCREATIC TUMORS

Juan Enrique Dominguez-Munoz  et al.

HISTOPATHOLOGICAL DIAGNOSIS OF SOLID PANCREATIC TUMORS FROM A PROSPECTIVE ENDOSCOPIC ULTRASOUND-BASED REGISTRY: NOT EVERYTHING IS PANCREATIC CANCER
HISTOPATHOLOGICAL DIAGNOSIS OF SOLID PANCREATIC TUMORS FROM A PROSPECTIVE ENDOSCOPIC ULTRASOUND-BASED REGISTRY: NOT EVERYTHING IS PANCREATIC CANCER

Juan Enrique Dominguez-Munoz  et al.

THE OBESTATIN/GPR39 SYSTEM REGULATES THE SYNTHESIS AND SECRETION OF PANCREATIC ENZYMES FORM ACINAR CELLS
THE OBESTATIN/GPR39 SYSTEM REGULATES THE SYNTHESIS AND SECRETION OF PANCREATIC ENZYMES FORM ACINAR CELLS

Juan Enrique Dominguez-Munoz  et al.

PROTEOMIC AND LIPIDOMIC ANALYSIS REVEAL ALTERATIONS OF COMPLEMENT ACTIVATION AND LIPID METABOLISM IN PERIPHERAL BLOOD MONONUCLEAR CELLS OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE
PROTEOMIC AND LIPIDOMIC ANALYSIS REVEAL ALTERATIONS OF COMPLEMENT ACTIVATION AND LIPID METABOLISM IN PERIPHERAL BLOOD MONONUCLEAR CELLS OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE

Juan Enrique Dominguez-Munoz  et al.

ACCURACY OF ENDOSCOPIC ULTRASOUND-GUIDED TISSUE ACQUISITION FOR THE CYTO-HISTOLOGICAL DIAGNOSIS OF SOLID PANCREATIC TUMORS: ANALISYS OF A LARGE PROSPECTIVE REGISTRY
ACCURACY OF ENDOSCOPIC ULTRASOUND-GUIDED TISSUE ACQUISITION FOR THE CYTO-HISTOLOGICAL DIAGNOSIS OF SOLID PANCREATIC TUMORS: ANALISYS OF A LARGE PROSPECTIVE REGISTRY

Juan Enrique Dominguez-Munoz  et al.

LIPOCALIN-2 LEVELS ARE ALTERED IN THE PANCREATIC JUICE OF EARLY CHRONIC PANCREATITIS PATIENTS AND ARE ASSOCIATED TO THE DEGREE OF EXOCRINE PANCREATIC DYSFUNCTION AND THE ACTIVE SMOKING HABIT
LIPOCALIN-2 LEVELS ARE ALTERED IN THE PANCREATIC JUICE OF EARLY CHRONIC PANCREATITIS PATIENTS AND ARE ASSOCIATED TO THE DEGREE OF EXOCRINE PANCREATIC DYSFUNCTION AND THE ACTIVE SMOKING HABIT

Juan Enrique Dominguez-Munoz  et al.

Endoscopic treatment of chronic pancreatitis: European Society of Gastrointestinal Endoscopy (ESGE) Guideline – Updated August 2018
Endoscopic treatment of chronic pancreatitis: European Society of Gastrointestinal Endoscopy (ESGE) Guideline – Updated August 2018

Juan Enrique Dominguez-Munoz  et al.

DISTINCTIVE CLINICAL FEATURES OF NON-ALCOHOLIC AND MIXED FATTY LIVER DISEASE
DISTINCTIVE CLINICAL FEATURES OF NON-ALCOHOLIC AND MIXED FATTY LIVER DISEASE

Juan Enrique Dominguez-Munoz  et al.

PREVALENCE AND RISK FACTORS ASSOCIATED WITH PROGRESSION TO ADVANCED FIBROSIS AND CIRRHOSIS IN NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD): ANALYSIS OF A PROSPECTIVE REGISTRY
PREVALENCE AND RISK FACTORS ASSOCIATED WITH PROGRESSION TO ADVANCED FIBROSIS AND CIRRHOSIS IN NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD): ANALYSIS OF A PROSPECTIVE REGISTRY

Juan Enrique Dominguez-Munoz  et al.

ACCURACY OF FIB-4 AND HEPAMET FIBROSIS SCORE TO IDENTIFY ADVANCED LIVER FIBROSIS IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD)
ACCURACY OF FIB-4 AND HEPAMET FIBROSIS SCORE TO IDENTIFY ADVANCED LIVER FIBROSIS IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD)

Juan Enrique Dominguez-Munoz  et al.

OPEN LABEL, RANDOMIZED, CROSSOVER CLINICAL TRIAL TO ASSESS THE EFFICACY OF INCREASING DOSES OF PANCREATIC ENZYMES, WITH OR WITHOUT INHIBITION OF GASTRIC ACID SECRETION, IN PATIENTS WITH PANCREATIC EXOCRINE INSUFFICIENCY SECONDARY TO CHRONIC PANCREATITIS
OPEN LABEL, RANDOMIZED, CROSSOVER CLINICAL TRIAL TO ASSESS THE EFFICACY OF INCREASING DOSES OF PANCREATIC ENZYMES, WITH OR WITHOUT INHIBITION OF GASTRIC ACID SECRETION, IN PATIENTS WITH PANCREATIC EXOCRINE INSUFFICIENCY SECONDARY TO CHRONIC PANCREATITIS

Juan Enrique Dominguez-Munoz  et al.

SURVEILLANCE OF CYSTIC PANCREATIC LESIONS IN PATIENTS OVER 75 YEARS OF AGE
SURVEILLANCE OF CYSTIC PANCREATIC LESIONS IN PATIENTS OVER 75 YEARS OF AGE

Juan Enrique Dominguez-Munoz  et al.

Item 1 - 18 / 18
1